PWP
ABBV icon

Perfromance Wealth Partners’s AbbVie ABBV Stock Holding History

Perfromance Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.35M Buy
37,161
+10,843
+41% +$2.33M 0.23% 28
2026
Q1 		$5.72M Sell
26,318
-906
-3% -$201K 0.17% 28
2025
Q4 		$6.22M Sell
27,224
-1,045
-4% -$238K 0.17% 27
2025
Q3 		$6.55M Sell
28,269
-461
-2% -$93.9K 0.18% 27
2025
Q2 		$5.33M Sell
28,730
-6
-0% -$1.11K 0.17% 29
2025
Q1 		$6.02M Sell
28,736
-4,799
-14% -$933K 0.22% 26
2024
Q4 		$5.96M Sell
33,535
-413
-1% -$75.9K 0.19% 24
2024
Q3 		$6.7M Sell
33,948
-816
-2% -$152K 0.23% 25
2024
Q2 		$5.96M Sell
34,764
-1,505
-4% -$249K 0.22% 23
2024
Q1 		$6.6M Sell
36,269
-2,082
-5% -$359K 0.28% 28
2023
Q4 		$5.94M Sell
38,351
-7,201
-16% -$1.05M 0.26% 30
2023
Q3 		$6.79M Sell
45,552
-1,702
-4% -$250K 0.33% 31
2023
Q2 		$6.5M Buy
47,254
+413
+0.9% +$60.6K 0.3% 29
2023
Q1 		$7.47M Sell
46,841
-24
-0.1% -$3.67K 0.38% 25
2022
Q4 		$7.57M Sell
46,865
-4,258
-8% -$653K 0.46% 25
2022
Q3 		$6.86M Sell
51,123
-78
-0.2% -$11.2K 0.4% 27
2022
Q2 		$7.84M Sell
51,201
-3,039
-6% -$464K 0.44% 26
2022
Q1 		$8.79M Buy
54,240
+199
+0.4% +$28.9K 0.38% 27
2021
Q4 		$7.32M Buy
+54,041
New +$6.38M 0.3% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Perfromance Wealth Partners's ABBV Position: Q2 2026 in Review

Perfromance Wealth Partners increased its AbbVie (ABBV) stake by 41% in Q2 2026, buying an estimated $2.33M and bringing the position to 37,161 shares worth $9.35M. The position accounts for 0.23% of the portfolio, ranked #28.

Perfromance Wealth Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Perfromance Wealth Partners held 37,161 shares of AbbVie worth $9.35M as of Q2 2026.
  • Perfromance Wealth Partners bought 10,843 AbbVie shares in Q2 2026, an estimated $2.33M.
  • AbbVie made up 0.23% of Perfromance Wealth Partners's portfolio in Q2 2026, its #28 holding.
  • Perfromance Wealth Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Perfromance Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.